Menu Back toAdvancing the Science of Patient Input: How are WE doing? Multi-Stakeholder Perspective

DIA 2021 Global Annual Meeting


Advancing the Science of Patient Input: How are WE doing? Multi-Stakeholder Perspective

Session Chair(s)

Pujita  Vaidya, MPH

Pujita Vaidya, MPH

  • Director, Global Regulatory and R&D Policy, Patient Centricity, Pediatrics, ROD
  • Amgen, United States
This forum will present current efforts and future opportunities to advance the incorporation of patient input into the medical product lifecycle. A panel of experts will discuss examples of how patient input have informed medical product decisions.
Learning Objective : Discuss current progress by key stakeholders in incorporating patient input into medical product development and regulatory decision-making; Discuss approaches and best practices to collect, analyze, assess quality, and present patient input; Identify opportunities for further enhancing the incorporation of patient input across the medical product lifecycle.

Speaker(s)

Michelle  Tarver, MD, PhD

Panelist

Michelle Tarver, MD, PhD

  • Deputy Director, Office of Strategic Partnerships & Technology Innovation, CDRH
  • FDA, United States
David S. Reasner, PhD

Panelist

David S. Reasner, PhD

  • Division Director, Division of Clinical Outcome Assessment, OND, CDER
  • FDA, United States
Annie  Kennedy

Panelist

Annie Kennedy

  • Chief of Policy and Advocacy
  • EveryLife Foundation for Rare Diseases, United States
Jessica S. Scott, JD, MD

Panelist

Jessica S. Scott, JD, MD

  • Head of R&D Patient Engagement Office
  • Takeda Pharmaceutical Company, United States
Robyn T. Carson, MPH

Panelist

Robyn T. Carson, MPH

  • Vice President, Patient-Centered Outcomes Research
  • Abbvie, United States